Workflow
金固股份前三季净利最高预增八成 五年半研发费达3.51亿布局机器人

Core Viewpoint - Jingu Co., Ltd. (金固股份) is experiencing steady growth in its core business, with a projected net profit of 40 million to 60 million yuan for the first three quarters of 2025, representing a year-on-year increase of 23.57% to 85.35% [1][5] Group 1: Business Performance - The company's Avatar low-carbon wheel business continues to grow, with new production capacity being gradually released following the launch of new production bases [1] - The automotive parts business is also maintaining stable growth, contributing to the overall positive performance [1] Group 2: Research and Development - Jingu Co., Ltd. is increasing its investment in independent innovation and research, particularly in the application of new materials in the robotics industry [1][4] - The company's R&D expenses have been rising annually, totaling 351 million yuan over five and a half years from 2020 to mid-2025 [4] Group 3: Expansion Plans - The company has accelerated its domestic and international expansion, with new production lines established in Hangzhou, Hefei, and Nanning, as well as two new lines overseas [2][3] - A strategic financing of 1.185 billion yuan has been completed to support the company's expansion plans [2] Group 4: International Market Development - Jingu Co., Ltd. has been proactive in overseas market development, having established a manufacturing plant in Thailand as early as 2012 [3] - The company is planning to build two new manufacturing plants for Avatar low-carbon wheels to meet the demands of European and American customers, with significant sales projections from long-term international contracts [3] Group 5: Robotics Sector Expansion - Beyond its core automotive wheel business, Jingu Co., Ltd. is expanding into the robotics industry, collaborating with companies like Luming Robotics to develop new materials for robotic applications [4] - The company is focusing on the industrialization of various new materials across different sectors, with several projects expected to achieve commercialization soon [4]